Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
59
×
Tags
biotech
59
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
startups
new york blog main
clinical trials
new york top stories
san diego blog main
san diego top stories
san francisco blog main
fda
national
san francisco top stories
cancer
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
indiana blog main
indiana top stories
boston
boulder/denver blog main
deals
boulder/denver top stories
detroit blog main
detroit top stories
investing
medical device
seattle blog main
seattle top stories
venture capital
wisconsin blog main
wisconsin top stories
amgen
medical devices
novartis
eli lilly
What
new
59
×
medicines
drug
biotech
drugs
fda
life
million
companies
company
medical
raised
startup
based
ipo
medicine
sciences
therapeutics
bio
cancer
diseases
research
san
science
approval
cells
class
developing
latest
lead
migraine
roundup
treat
year
adds
advance
announced
called
develop
device
Language
unset
unknown
Current search:
new
×
biotech
×
photo
×
@techcrunch.com
3 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@extremetech.com
1 year ago
AI Helps Biotech Labs Generate the Building Blocks for New Drugs
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@tech.eu
2 years ago
Why biotech investors are attracted to Lithuania
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@techcrunch.com
2 years ago
A magnetic helmet shrunk a deadly tumor in world-first test
@techcrunch.com
3 years ago
‘It’s almost like placing an IV’: Brain monitoring electrode receives FDA 510(k) clearance
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@tech.eu
3 years ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@techcrunch.com
4 years ago
Google’s SMILY is reverse image search for cancer diagnosis
@xconomy.com
5 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Corza Health Emerges Led by Former NuVasive, GreatCall Executives
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
First
Prev
Page 1
(current)
Next
Last